Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Baxter
Merck
Medtronic
AstraZeneca

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

TORA Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Tora, and what generic alternatives are available?

Tora is a drug marketed by Solvay and Roche Palo and is included in three NDAs.

The generic ingredient in TORA is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.

Summary for TORA
Drug patent expirations by year for TORA
Synonyms for TORA
.alpha.-Methylamphetamine hydrochloride
.alpha.,.alpha.-Dimethylphenethylamine hydrochloride
(1,1-DIMETHYL-2-PHENYL)ETHYLAMINE HYDROCHLORIDE
0K2I505OTV
1-Phenyl-2-methyl-2-aminopropane hydrochloride
1-phenyl-2-methyl-2-aminopropanehydrochloride
1-Phenyl-2-methyl-2-propylamine Hydrochloride
1,1-Dimethyl-2-phenylethylamine hydrochloride
1197-21-3
122-09-8 (Parent)
2-Amino-2-methyl-1-phenylpropane hydrochloride
2-methyl-1-phenyl-2-propanamine hydrochloride
2-Methyl-1-phenylpropan-2-amine hydrochloride
2-methyl-1-phenylpropan-2-amine;hydrochloride
AC1L2F9M
Adipex-P
Adipex-p (TN)
AKOS015891196
alpha-Methylamphetamine hydrochloride
alpha-methylamphetaminehydrochloride
alpha,alpha-dimethyl-phenethylaminhydrochloride
alpha,alpha-Dimethylphenethylamine hydrochloride
ANW-58508
AOB5784
API0007710
AS01627
BCP23776
Benzeneethanamine, alpha,alpha-dimethyl-, hydrochloride
Benzeneethanamine, alpha,alpha-dimethyl, hydrochloride
Benzeneethanamine,.alpha.-dimethyl, hydrochloride
benzeneethanamine,alpha,alpha-dimethyl,hydrochloride
CCG-221139
CHEBI:50506
CHEMBL1200912
CTK6A7128
D05459
DEA No. 1640
DTXSID20152550
Duromine Hydrochloride
EINECS 214-821-9
Fastin
Fastin (TN)
FT-0673716
I01-8880
I14-44888
Inoamin Hydrochloride
Ionamin Hydrochloride
Linyl Hydrochloride
Lipopill Hydrochloride
Lomaira
Lonamin Hydrochloride
LS-103359
MG 18370
MG 18570
Mirapront Hydrochloride
MLS003882563
NCAIGTHBQTXTLR-UHFFFAOYSA-N
Normephentermine Hydrochloride
NSC 44090
NSC-44090
NSC44090
Obestin-30
Oby-Trim
Omnibex Hydrochloride
Ona Mast
Ona-Mast
Ona-Mast hydrochloride
Phenethylamine, alpha,alpha-dimethyl-, hydrochloride
Phenteral
Phenteramine hydrochloride
Phentermine HCl
Phentermine hydrochloride
Phentermine hydrochloride (USP)
Phentermine hydrochloride [USAN]
Phentermine hydrochloride [USP]
Phentermine hydrochloride, >=98% (HPLC)
Phentermine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Phentermyl Wyncaps
Phenyl-t-butylamine hydrochloride
phenyl-t-butylaminehydrochloride
Phenyl-tert-butylamine Hydrochloride
S 58
SCHEMBL41585
SMR000058739
Suprenza
TC-147253
TL8000587
UNII-0K2I505OTV
Wilpo (VAN)
Wilpo Hydrochloride
wilpohydrochloride
WLN: ZX1&1&1R &GH

US Patents and Regulatory Information for TORA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay TORA phentermine hydrochloride TABLET;ORAL 084035-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roche Palo TORADOL ketorolac tromethamine TABLET;ORAL 019645-001 Dec 20, 1991 DISCN Yes No   Start Trial   Start Trial   Start Trial
Roche Palo TORADOL ketorolac tromethamine INJECTABLE;INJECTION 019698-001 Nov 30, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
Roche Palo TORADOL ketorolac tromethamine INJECTABLE;INJECTION 019698-002 Nov 30, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Harvard Business School
Dow
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.